Carregant...
Dapagliflozin-induced Late-onset Euglycemic Diabetic Ketoacidosis
Sodium-glucose co-transporter-2 (SGLT2) inhibitors are a class of oral hypoglycemics that improve glycemic control by increasing the urinary excretion of glucose. They gained widespread popularity because they not only showed improved glycemic control but also had a favorable effect on weight loss,...
Guardat en:
| Publicat a: | Cureus |
|---|---|
| Autors principals: | , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Cureus
2019
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6897349/ https://ncbi.nlm.nih.gov/pubmed/31857921 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7759/cureus.6089 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|